Ola M Saad (Ola Saad)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Venues

Nature communications

Analytical chemistry

mAbs

Molecular cancer research : MCR

This page only lists publications with an associated author ORCID identifier.

Publications

Gail D Lewis, Guangmin Li, Jun Guo, Shang-Fan Yu, Carter T Fields, Genee Lee, Donglu Zhang, Peter S Dragovich, Thomas Pillow, BinQing Wei, Jack Sadowsky, Douglas D Leipold, Tim Wilson, Amrita Kamath, Michael Mamounas, M Violet Lee, Ola M Saad, Voleak Choeurng, Alexander Ungewickell, Sharareh Monemi, Lisa Crocker, Kevin Kalinsky, Shanu Modi, Kyung Hae Jung, Erika Paige Hamilton, Patricia M LoRusso, Ian Krop, Melissa M Schutten, Renee Commerford, Mark X Sliwkowski, Eunpi Cho
The HER2-directed antibody-drug conjugate DHES0815A in advanced and/or metastatic breast cancer: preclinical characterization and phase 1 trial results. Nature communications 15 (1) (2024)
Gail D Lewis, Guangmin Li, Jun Guo, Shang-Fan Yu, Carter T Fields, Genee Lee, Donglu Zhang, Peter S Dragovich, Thomas Pillow, BinQing Wei, Jack Sadowsky, Douglas D Leipold, Tim Wilson, Amrita Kamath, Michael Mamounas, M Violet Lee, Ola M Saad, Voleak Choeurng, Alexander Ungewickell, Sharareh Monemi, Lisa Crocker, Kevin Kalinsky, Shanu Modi, Kyung Hae Jung, Erika Paige Hamilton, Patricia M LoRusso, Ian Krop, Melissa M Schutten, Renee Commerford, Mark X Sliwkowski, Eunpi Cho
The HER2-directed antibody-drug conjugate DHES0815A in advanced and/or metastatic breast cancer: preclinical characterization and phase 1 trial results. Nature communications 15 (1) (2024)
Gail D Lewis, Guangmin Li, Jun Guo, Shang-Fan Yu, Carter T Fields, Genee Lee, Donglu Zhang, Peter S Dragovich, Thomas Pillow, BinQing Wei, Jack Sadowsky, Douglas D Leipold, Tim Wilson, Amrita Kamath, Michael Mamounas, M Violet Lee, Ola M Saad, Voleak Choeurng, Alexander Ungewickell, Sharareh Monemi, Lisa Crocker, Kevin Kalinsky, Shanu Modi, Kyung Hae Jung, Erika Paige Hamilton, Patricia M LoRusso, Ian Krop, Melissa M Schutten, Renee Commerford, Mark X Sliwkowski, Eunpi Cho
The HER2-directed antibody-drug conjugate DHES0815A in advanced and/or metastatic breast cancer: preclinical characterization and phase 1 trial results. Nature communications 15 (1) (2024)
Gail D Lewis, Guangmin Li, Jun Guo, Shang-Fan Yu, Carter T Fields, Genee Lee, Donglu Zhang, Peter S Dragovich, Thomas Pillow, BinQing Wei, Jack Sadowsky, Douglas D Leipold, Tim Wilson, Amrita Kamath, Michael Mamounas, M Violet Lee, Ola M Saad, Voleak Choeurng, Alexander Ungewickell, Sharareh Monemi, Lisa Crocker, Kevin Kalinsky, Shanu Modi, Kyung Hae Jung, Erika Paige Hamilton, Patricia M LoRusso, Ian Krop, Melissa M Schutten, Renee Commerford, Mark X Sliwkowski, Eunpi Cho
The HER2-directed antibody-drug conjugate DHES0815A in advanced and/or metastatic breast cancer: preclinical characterization and phase 1 trial results. Nature communications 15 (1) (2024)
Gail D Lewis, Guangmin Li, Jun Guo, Shang-Fan Yu, Carter T Fields, Genee Lee, Donglu Zhang, Peter S Dragovich, Thomas Pillow, BinQing Wei, Jack Sadowsky, Douglas D Leipold, Tim Wilson, Amrita Kamath, Michael Mamounas, M Violet Lee, Ola M Saad, Voleak Choeurng, Alexander Ungewickell, Sharareh Monemi, Lisa Crocker, Kevin Kalinsky, Shanu Modi, Kyung Hae Jung, Erika Paige Hamilton, Patricia M LoRusso, Ian Krop, Melissa M Schutten, Renee Commerford, Mark X Sliwkowski, Eunpi Cho
The HER2-directed antibody-drug conjugate DHES0815A in advanced and/or metastatic breast cancer: preclinical characterization and phase 1 trial results. Nature communications 15 (1) (2024)
Gail D Lewis, Guangmin Li, Jun Guo, Shang-Fan Yu, Carter T Fields, Genee Lee, Donglu Zhang, Peter S Dragovich, Thomas Pillow, BinQing Wei, Jack Sadowsky, Douglas D Leipold, Tim Wilson, Amrita Kamath, Michael Mamounas, M Violet Lee, Ola M Saad, Voleak Choeurng, Alexander Ungewickell, Sharareh Monemi, Lisa Crocker, Kevin Kalinsky, Shanu Modi, Kyung Hae Jung, Erika Paige Hamilton, Patricia M LoRusso, Ian Krop, Melissa M Schutten, Renee Commerford, Mark X Sliwkowski, Eunpi Cho
The HER2-directed antibody-drug conjugate DHES0815A in advanced and/or metastatic breast cancer: preclinical characterization and phase 1 trial results. Nature communications 15 (1) (2024)
Suk-Joon Hyung, Douglas D Leipold, Donna W Lee, Surinder Kaur, Ola M Saad
Multiplexed Quantitative Analysis of Antibody-Drug Conjugates with Labile CBI-Dimer Payloads In Vivo Using Immunoaffinity LC-MS/MS. Analytical chemistry 94 (2) (2021)
Vineesh Indira Chandran, Ann-Sofie Månsson, Magdalena Barbachowska, Myriam Cerezo-Magaña, Björn Nodin, Bharat Joshi, Neelima Koppada, Ola M Saad, Oleg Gluz, Karolin Isaksson, Signe Borgquist, Karin Jirström, Ivan Robert Nabi, Helena Jernström, Mattias Belting
Hypoxia Attenuates Trastuzumab Uptake and Trastuzumab-Emtansine (T-DM1) Cytotoxicity through Redistribution of Phosphorylated Caveolin-1. Molecular cancer research : MCR 18 (4) (2020)
M Violet Lee, Surinder Kaur, Ola M Saad
Conjugation Site Influences Antibody-Conjugated Drug PK Assays: Case Studies for Disulfide-Linked, Self-Immolating Next-Generation Antibody Drug Conjugates. Analytical chemistry 92 (18) (2020)
Rong Deng, Chenguang Zhou, Dongwei Li, Hao Cai, Siddharth Sukumaran, Montserrat Carrasco-Triguero, Ola M Saad, Denise Nazzal, Christopher Lowe, Saroja Ramanujan, Amrita V Kamath
Preclinical and translational pharmacokinetics of a novel THIOMAB™ antibody-antibiotic conjugate against Staphylococcus aureus. mAbs 11 (6) (2019)
Shun Xin Wang Lin, Chenguang Zhou, Amrita V Kamath, Kyu Hong, Neelima Koppada, Ola M Saad, Montserrat Carrasco-Triguero, Cyrus Khojasteh, Rong Deng
Minimal physiologically-based pharmacokinetic modeling of DSTA4637A, A novel THIOMAB™ antibody antibiotic conjugate against Staphylococcus aureus, in a mouse model. mAbs 10 (7) (2018)

Ola M Saad.css-eqlu8i{font-size:small;padding-left:4px;} (Ola Saad)

Publication Activity (10 Years)

Top Topics

Top Venues

Ola M Saad (Ola Saad)